ECMO Market Opportunity with

Prof. Dr. Peter Borges

Lastest News From Hemovent GmbH

June 12, 2017

Hemovent successfully completes first series of in vivo trials of its next-gen ExtraCorporeal Life Support (ECLS) system

April 24, 2017

Hemovent receives government grant to fast-forward development of its next-gen artificial lung technologies

March 22, 2017

Hemovent files two additional patent applications for its portable ECMO device for both circulatory and respiratory support

April 25, 2016

Number of ECMO applications has tripled in five years

February 10, 2016

Hemovent Raises $6 Million in Series A Funding